Flibanserin
Composition
Fevigra Tablet: Each film coated tablet contains Flibanserin INN 100 mg.
Indications
Flibanserin is indicated for the treatment of premenopausal women with
acquired or generalized hypoactive sexual desire disorder (HSDD).
Dosage & Administration
The recommended dosage of Flibanserin is 100 mg administered once per
day at bedtime. Or as directed by the physician
Ferric Maltol
Composition
Malifa 30:
Each capsule contains Ferric Maltol INN
equivalent to Iron 30 mg.
Pharmacology
Ferric Maltol delivers iron for uptake across the intestinal
wall and transfers to transferrin and ferritin. It has been
shown to increase serum iron parameters, including ferritin
and transferrin saturation. Ferric Maltol dissociates upon
uptake from the Gastrointestinal Tract allowing iron and
maltol to be absorbed separately. The iron is absorbed
across the intestinal wall and transfer to transferrin and
ferritin. It increases serum iron parameters, including ferritin
and transferrin saturation.
Total serum iron peak values were reached 1.5 to 3 hours
after administration. Food has been shown to decrease the
bioavailability of iron after administration of ferric maltol.
Around 60% of ferric maltol is excreted in the urine as
glucuronide conjugate. Iron and ferric maltol are not
excreted in the urine and unabsorbed ferric maltol is
eliminated in the feces.
Indications
It is indicated for the treatment of iron deficiency in adults.
Dosage & Administration
30 mg twice daily on an empty stomach (Morning &
Evening).
• Continue as long as necessary to replenish body iron
stores or as directed by the physician.
Contraindications
It is contraindicated in patients with a history of:
• Hypersensitivity to the active substance or to any of the
excipients.
• Hemochromatosis and other iron overload syndromes
• Receiving repeated blood transfusions.
Warnings & Precautions
Avoid use of Ferric Maltol in patients with an active
inflammatory bowel disease (IBD) flare, as there is potential
risk of increased inflammation in the gastrointestinal tract.
• Excessive therapy with iron drugs can lead to excess
storage of iron with the possibility of iatrogenic
hemosiderosis.
• Accidental overdose of iron-containing drugs is a leading
cause of fatal poisoning in children under 6 years.
Side Effects
The most common side effects include gas, diarrhoea,
constipation, discolored stools, stomach pain, nausea or
vomiting and stomach area discomfort or bloating.
Use in Pregnancy & Lactation
In a clinical study, it has been found that oral use of Ferric
Iron in pregnant women indicate no malformative nor feto
toxicity. Ferric Maltol may be considered during pregnancy
if necessary.
There is no effects of oral Ferric Iron in breastfeed
newborns or infants of treated mother. Ferric Maltol can be
used during breastfeeding if clinically needed.
Use in Children & Adolescents
Safety and effectiveness of Ferric Maltol have not been
established in paediatric patients.
Drug Interactions
Dimercaprol: Concomitant use of iron products with
dimercaprol may increase the risk of nephrotoxicity.
The absorption of certain oral medications decreases such
as bisphosphonates, levodopa, thyroid medications and
tetracycline antibiotics when given together with iron.
Overdosage
Early signs and symptoms of iron overdosage may include
nausea, vomiting, abdominal pain and diarrhoea. In more
serious cases, hypoperfusion, metabolic acidosis and
systemic toxicity are observed. Dosages of excess iron may
lead to hemosiderosis.
Storage
Store below 30°C, away from light and in a dry place. Keep
all medicines out of reach of children.
Fluticasone Propionate + Azelastine
Composition:
Flutispray™ Plus: Each spray delivers Fluticasone Propionate BP 50 meg and Azelastine hydrochloride BP 137 meg.
Indication:
Flutispray™ Plus is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 6 years of age and older who require treatment with both Azelastine Hydrochloride and Fluticasone Propionate for symptomatic relief.
Dose and Administration:
The recommended dosage of Flutispray™ Plus is one spray in each nostril twice daily.
Fluticasone Propionate
Composition:
Flutispray™ Nasal Spray: Each spray contains
Fluticasone Propionate BP 50 meg.
Indication:
Flutispray™ is indicated for the management of the nasal symptoms of seasonal & perennial allergic & non-allergic rhinitis in adults and paediatric patient 4 years of age and older.
Dose & Administration:
Adults 02 (two) sprays in each nostril once daily, preferably in the morning.
In some cases, 02 (two) sprays in each nostril twice daily may be required or as directed by the physician.
Total daily doses of 200 meg (04 sprays) should not generally be exceeded.
Children (4 to 11 years of age) 01 (one) spray in each nostril once daily. In some cases, 01 (one) spray in each nostril twice daily may be required or as directed by the physician.
Total daily doses of 100 meg (2 sprays) should not generally be exceeded or as directed by the physicians
Ferric Iron (As Ferric Citrate)
Composition:
Phoscon™ Tablet: Each film coated tablet contains Ferric Citrate INN equivalent to Ferric Iron 210 mg.
Indication:
• The control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis
• The treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis
Dose & Administration:
Hyperphosphatemia in Chronic Kidney Disease on Dialysis:
• Starting dose is 2 tablets orally 3 times per day with meals
• Adjust dose by 1 to 2 tablets as needed to maintain serum phosphorus at target levels, up to a maximum of 12 tablets daily. Dose can be titrated at 1-week or longer intervals.
Iron DeficiencyAnemia in Chronic Kidney Disease not on Dialysis:
• Starting dose is 1 tablet orally 3 times per day with meals
• Adjust dose as needed to achieve and maintain hemoglobin goal, up to a maximum of 12 tablets daily or as directed by the physician.
Flupentixol+ Melitracen
Composition:
Meltix™ Tablet: Each film coated tablet contains Flupentixol
Dihydrochloride BP equivalent to 0.5 mg Flupentixol and Melitracen Hydrochloride INN equivalent to 10 mg Melitracen.
Indications:
It is indicated in various types of anxiety, depression and apathy.
These include-) Psychogenic depression
a. Depressive neurosis
b. Masked depression
c. Psychosomatic affections accompanied by anxiety and apathy.
d. Menopausal depressions
e. Dysphoria and depression in alcoholics and drug-addicts.
Dosage & Administration:
Adults : Usually 2 tablets daily at morning and noon. In severe cases the
morning dose may be increased to 2 tablets.
Elderly patients : 1 tablet in the morning.
Maintenance dose : Usually 1 tablet in the morning. In cases of insomnia or severe restlessness additional treatment with a sedative in acute phase is recommended. Or as directed by the physician.
Flucloxacillin
Composition:
Flubiotic 250 Capsule: Each capsule contains flucloxacillin sodium BPequivalent to 250 mg flucloxacillin.
Flubiotic 500 Capsule: Each capsule contains flucloxacillin sodium BPequivalent to 500 mg flucloxacillin.
Flubiotic Powder for Syrup: Each 5 ml reconstituted syrup contains flucloxacillin sodium BP equivalent to 125 mg flucloxacillin.
Indications:
Flucloxacillin is indicated for the treatment of infections due to gram positive organisms,
(including infections caused by beta-lactamase producing staphylococci).
Dosage and Administration:
Oral dosage should be administered half to one hour before meal or two hour after meal.Usual adult dose (including elderly patients): Oral 250 mg four times daily. Dosage may be
doubled in severe infections. Osteomyelitis, endocarditis: up to 8 gm daily in divided doses (6 to 8 hourly) or as directed by the physician.
Fexofenadine
Composition:
Odafen™ 120: Each film coated tablet contains Fexofenadine
Hydrochloride USP 120 mg.
Odafen™ 180: Each film coated tablet contains Fexofenadine
Hydrochloride USP 180 mg.
Odafen™ Suspension: Each 5 ml suspension contains Fexofenadine Hydrochloride USP 30 mg.
Indication:
Seasonal Allergic Rhinitis:
Odafen™ tablet are indicated for the relief of symptoms
associated with seasonal allergic rhinitis in adults and children 6 years of age and older. Odafen™ oral suspension is indicated for the relief of symptoms associated with seasonal allergic rhinitis in children 2 to 11 years of age. Symptoms to treat
effectively:
sneezing, rhinorrhea, itchy nose/palate/throat, itchy/watery/red eyes.
Chronic Idiopathic Urticaria:
Odafen™ of Chronic Idiopathic Urticaria in adults and children 6 years of age and
older.
Odafen™ manifestations of Chronic Idiopathic Urticaria in children 6 months to 11 years
of age. Fexofenadine Hydrochloride significantly reduces pruritus and the number
of wheals.
Flunarizine
Composition
Imigra™ 5 Tablet: Each film coated tablet contains Flunarizine Dihydrochloride BP equivalent to 5 mg Flunarizine.
Imigra™ 10 Tablet: Each film coated tablet contains Flunarizine Dihydrochloride BP equivalent to 10 mg Flunarizine.
Imigra™ 5 Capsule: Each capsule contains Flunarizine Dihydrochloride BP equivalent to 5 mg Flunarizine.
Imigra™ 10 Capsule: Each capsule contains Flunarizine Dihydrochloride BP equivalent to 10 mg Flunarizine
Indication
O Symptomatic treatment of vestibular vertigo & dizziness.
O Peripheral vascular diseases (Intermittent claudication, Raynaud's phenomenon, paresthesia, cold extremities etc.).
O Epilepsy resistant to conventional anti-epileptic therapy.
O Prophylaxis of classic (with aura) or common (without aura) migraine.
Dose and Administration
For vertigo: The recommended maximum daily dose of Flunarizine in the treatment of vertigo is 10 mg daily in adults and 5 mg daily in children (<40 kg).
For epilepsy: An optimal therapeutic dosage in epileptic patients receiving other anti-epileptic drug is 15 mg to 20 mg daily in adults and 5 to 10 mg daily in children.
For migraine prophylaxis: Starting dose is 10 mg daily at night for adult patients less than 65 years of age and 5 mg daily for patients older than 65 years.
Maintenance treatment: If a patient's response is satisfactory and if a maintenance treatment is needed, the dose should be decreased. The patient should have 5 days treatment in a week at the same daily dose and 2 successive drug free days. Treatment should be stopped after 6 months and reinitiated only if the patient relapses.
Or as directed by the physician
